Literature DB >> 15761543

[11beta-hydroxylase deficiency].

Maricilda Palandi Mello1, Junia Yara Penachioni, Fernando C do Amaral, Margaret de Castro.   

Abstract

Congenital adrenal hyperplasia due to 11beta-hydroxylase enzyme deficiency is a result of the impairment of 11-deoxycortisol to cortisol conversion. In general, it is responsible for less than 5% of the congenital adrenal hyperplasia cases. The clinical expression of androgen excess in females includes several degrees of genital ambiguity, varying from clitoromegaly to complete virilization. Due to the accumulation of mineralocorticoids, approximately 50% of the patients develop blood hypertension. Mutations in the CYP11B1 gene are responsible for the disease. Biochemical and molecular characteristics of the enzyme and their implications in the clinical presentation of 11beta-hydroxylase deficiency are reviewed here.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761543     DOI: 10.1590/s0004-27302004000500018

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  1 in total

Review 1.  Insights on the phenotypic heterogenity of 11β-hydroxylase deficiency: clinical and genetic studies in two novel families.

Authors:  Luciana Pinto Valadares; Alessandra Christine Vieira Pfeilsticker; Selma Moreira de Brito Sousa; Sarah Caixeta Cardoso; Olivia Laquis de Moraes; Luiz Claudio Gonçalves de Castro; Renata Santarem de Oliveira; Adriana Lofrano-Porto
Journal:  Endocrine       Date:  2018-09-21       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.